MIR3926-1

Across TCGA pan-cancer cohorts, MIR3926-1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR3926-1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3926-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3926-1 expression acts as an unfavorable survival marker, although some lineages such as LIHC and PRAD show a favorable association.

MESO, BRCA, and LIHC are the cancer types where MIR3926-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.195	0.577	.023	27	view →
BRCA	DFS	Tertile	All	0.874	0.910	.005	24	view →
LIHC	OS	Tertile	II,III,IV	1.000	0.415	.029	24	view →
UVM	DFS	Median	III,IV	0.372	0.685	.017	18	view →
ACC	DFS	Tertile	IV	0.057	0.404	.011	18	view →
PRAD	DFS	Tertile	All	0.898	0.743	.013	18	view →
HNSC	OS	Tertile	All	0.526	0.720	.026	15	view →
STAD	OS	Tertile	All	0.536	0.326	.019	11	view →
LAML	DFS	Quartile	All	0.744	0.467	.018	10	view →
BLCA	OS	Tertile	IV	0.181	0.323	.027	9	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →
OV	OS	Tertile	IV	0.939	0.656	.043	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR3926-1–MESO (OS)

Open the MESO breakdown →